drugset / Trial / NCT00373204
Study of the Effect on Non-small Cell Lung Cancer of the Investigational Drug Motexafin Gadolinium When Used in Combination With Docetaxel (Taxotere)
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine if the addition of motexafin gadolinium (study drug) to standard treatment with docetaxel will improve the response rate in patients with non-small cell lung cancer.
Timeline
- Start
- 2006-05
- Primary completion
- 2008-02
- Completion
- 2008-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | motexafin gadolinium | Diagnostic / imaging agent | 10 mg/kg | — |
| Background | Docetaxel | Small molecule | 75 mg/m2 | Intravenous |